Intraperitoneal injection of ART in a xenograft model of human CML KMB-5 cells resulted in a significant suppression of tumor progression and suppression of phosphorylation of p38/ERK/STAT5/CREB in ART-treated tumor tissues. Here, STAT5B is linked to chronic myelogenous leukemia, BCR-ABL1 positive.